BMC Women’s Health is pleased to welcome submissions to the Collection Considering future fertility in survivors of gynecological cancers and other disorders.
Gynecological neoplasms are considered the most common cancers among women worldwide. A significant number of premenopausal women will experience infertility as a result of their cancer treatment. The psychological and physical impact of losing fertility can be complex and lead women to experience menopausal symptoms, changes in sexual function and high levels of distress. Oncofertility was established as an interdisciplinary field with the purpose of preserving the reproductive function of cancer patients whose treatment may have compromised their fertility. Several currently recommended options for fertility preservation are available for women with early stage gynecologic cancers, including conservative, fertility-sparing, medical and surgical management; therefore, patients should be carefully counseled about fertility preservation, and be informed about the options provided by assisted reproductive technology.
The primary aim of the Collection is to encourage novel key articles about cutting-edge advancements, challenges, and legal and ethical considerations surrounding future fertility options for individuals undergoing treatment for gynecological cancers and other reproductive health related disorders. It would be useful to discuss the long-term consequences and success of the various fertility treatments and benefits for different models of care. Lastly, it would be useful to focus on the development of strategies to identify, monitor, and address, in a clinical care setting, the issues these cancer survivors face.
We invite oncologists, gynecologists, reproductive biologists, psychologists and researchers in related fields to contribute their robust scientific manuscripts on fertility in survivors of gynecological cancers and related disorders. Key topics of interest include but are not limited to:
- Novel techniques to advance early diagnosis and treatment of gynecological cancers including hereditary malignant tumors.
- Innovative and effective approaches, technologies, and therapeutic strategies for fertility preservation in gynecological cancer patients, including oocyte, embryo, ovarian tissue cryopreservation, and ovarian transposition.
- Investigating efficient and safe fertility restoration techniques following cancer remission or completion of treatment, such as ovarian tissue transplantation, in vitro maturation of oocytes, and optimized hormonal therapies to recover or improve ovarian function.
- Professional oncofertility support to relieve mental stress and provide legally and ethically professional knowledge, and strategies to leverage the endocrine health, fertility management and well-being of patients.
- Integral systems or platforms to evaluate the efficacy of fertility preservation and/or restoration, and impact of these interventions on long-term quality of life.
Image credit: © Tinnakorn / Stock.adobe.com